Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content
Full access
Editorials
Published Online: 1 November 2020

Social Determinants of Health and Smoking Cessation: A Challenge

For the United States, the 1964 Surgeon General’s Advisory Committee report marked a sea change in public attitudes about smoking (1). In addition, the public health community established and maintained a comprehensive tobacco control effort, including restrictions on smoking in worksites and other public places, tobacco taxation, increased access to evidence-based tobacco treatment, and public health national media campaigns (2). This comprehensive tobacco control effort is a public health success story. In 1965, 42% of adults were current smokers, and smoking rates had fallen to 15% in 2014 (3). Whereas smoking was once allowed everywhere, from hospitals to airplanes, and it was common to see celebrities, athletes, and health care providers advertising cigarettes, labeling changes and advertising restrictions, another arm of the antismoking public health campaign (4), also contributed to the decrease in cigarette smoking.
In spite of this success, tobacco use remains the leading cause of preventable morbidity and mortality among adults in the United States and worldwide (3, 5). In fact, while there were large reductions in the prevalence of daily smoking at the global level between 1980 and 2012 (6), because of population growth, the actual number of smokers increased significantly. The article by Grant and colleagues (7) in this issue of the Journal tells another, less encouraging piece of this story. These investigators use data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) to compare changes in 12-month prevalence of nicotine use, DSM-IV nicotine dependence, and nicotine dependence among all nicotine users between 2001–2002 and 2012−2013 to test the “hardening hypothesis.” The hardening hypothesis posits that the decline in nicotine use resulting from population-level control measures leaves a growing proportion of highly dependent users. Grant and colleagues found smaller increases in 12-month nicotine use relative to larger increases in nicotine dependence and nicotine dependence among users, supporting the hardening hypothesis. Of interest, increases in nicotine use, nicotine dependence, and nicotine dependence among users were especially notable among individuals with lower education and income, and changes over time in these nicotine outcomes were greater among those with lower socioeconomic status relative to those with greater income and education. We know that socioeconomic status is an important factor in morbidity and mortality, and smoking is likely an important contributor to socioeconomic status differences in mortality. One study estimated that at least half of the socioeconomic status differences in mortality among men ages 35–69 years in England, Wales, Poland, and North America were related to smoking (8).
Low socioeconomic status interacts with an array of other factors to influence smoking behavior, including race/ethnicity, cultural characteristics, social marginalization (e.g., lesbian, gay, bisexual, and transgender communities, people with mental illness and substance use disorders), stress, and lack of community empowerment. There is a growing awareness that these social determinants of health, largely outside the realm of traditional medicine, have a great impact on health and well-being. While low education and income are the main social determinants of health that can determine increased tobacco use, other related ones, such as the unequal distribution of resources and services, can also lead to inequities in tobacco prevention and control and disparities in tobacco use. Taking a social determinants of health approach in tobacco prevention and control (changing environmental context and ensuring equal distribution of resources and services) will be necessary to achieve equity and eliminate tobacco-related disparities (9). At a time when social inequities are an object of widespread attention, looking at one of our greatest public health achievements through the lens of social determinants of health is essential to improve tobacco dependence and inform future public health campaigns.
The Grant et al. article calls to mind another issue of grave concern to those of us who work in the mental health area. A disproportionate number of individuals with psychiatric illness smoke cigarettes. In an earlier study using NESARC data, Grant and colleagues (10) found that associations between nicotine dependence and axis I and II disorders were all positive, strong, and statistically significant. Individuals with current nicotine dependence and at least one comorbid psychiatric disorder made up 7.1% of the U.S. adult population, yet they consumed 34.2% of all cigarettes smoked. People with mental illness have a shorter lifespan than the general population (11), and smoking contributes to their additional risk of mortality and morbidity (12), yet relatively few studies have focused on smoking cessation for individuals with co-occurring psychiatric illness.
One unspoken element of the hardening hypothesis is that as a behavior becomes less mainstream, those who engage in it become marginalized. The hard-hitting anti-tobacco public health campaign, focused on awareness of health consequences of smoking and denormalizing smoking behavior, may have the unintended consequences of stigmatizing smoking and smoking-related illnesses (13). Stigma can impede treatment seeking and adherence. Stigma is also often internalized and can contribute to social isolation and psychosocial distress, which increase the likelihood of continued substance use (14). Both low socioeconomic status and psychiatric illness are also associated with stigma, so smoking-related stigma compounds an already difficult situation.
Smoking remains one of the most preventable sources of morbidity and mortality in the world, and it is disproportionately affecting the health and well-being of individuals of low socioeconomic status, including those with psychiatric illnesses. This population is less likely to have access to the resources available to help with smoking cessation and more likely than ever to feel stigmatized. Clearly, if we are committed to addressing health inequities, efforts and resources must be dedicated to finding evidence-based smoking cessation treatment interventions and public health activities that target the specific populations who continue to suffer the most severe consequences from nicotine dependence. While progress has been made in smoking cessation, the hardest work still lies ahead.

References

1.
Cummings KM, Proctor RN: The changing public image of smoking in the United States: 1964–2014. Cancer Epidemiol Biomarkers Prev 2014; 23:32–36
2.
Centers for Disease Control and Prevention: Best Practices for Comprehensive Tobacco Control Programs—2014. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014 (https://www.cdc.gov/tobacco/stateandcommunity/best_practices/pdfs/2014/comprehensive.pdf)
3.
Department of Health and Human Services: The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health, 2014 (https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf)
4.
Federal Trade Commission: Report to Congress Pursuant to the Federal Cigarette Labeling and Advertising Act. Washington, DC, United States Federal Trade Commission, 1967
5.
World Health Organization: Tobacco Fact Sheet. Geneva, World Health Organization, 2014
6.
Ng M, Freeman MK, Fleming TD, et al: Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 2014; 311:183–192
7.
Grant BF, Shmulewitz D, Compton WM: Nicotine use and DSM-IV nicotine dependence in the United States, 2001–2002 and 2012–2013. Am J Psychiatry 2020; 177:1082–1090
8.
Jha P, Peto R, Zatonski W, et al: Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet 2006; 368:367–370
9.
Garrett BE, Dube SR, Babb S, et al: Addressing the social determinants of health to reduce tobacco-related disparities. Nicotine Tob Res 2015; 17:892–897
10.
Grant BF, Hasin DS, Chou SP, et al: Nicotine dependence and psychiatric disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61:1107–1115
11.
World Health Organization: Premature Death Among People With Severe Mental Disorders. Geneva, World Health Organization, 2017 (https://www.who.int/mental_health/management/info_sheet.pdf)
12.
Bandiera FC, Anteneh B, Le T, et al: Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One 2015; 10:e0120581
13.
Riley KE, Ulrich MR, Hamann HA, et al: Decreasing smoking but increasing stigma? Anti-tobacco campaigns, public health, and cancer care. AMA J Ethics 2017; 19:475–485
14.
Volkow ND: Stigma and the toll of addiction. N Engl J Med 2020; 382:1289–1290

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1029 - 1030

History

Accepted: 17 September 2020
Published online: 1 November 2020
Published in print: November 01, 2020

Keywords

  1. Nicotine Use Disorder
  2. Nicotine Dependence
  3. Epidemiology

Authors

Details

Kathleen T. Brady, M.D., Ph.D. [email protected]
Department of Psychiatry, Medical University of South Carolina, Charleston.

Notes

Send correspondence to Dr. Brady ([email protected]).

Funding Information

Disclosures of Editors’ financial relationships appear in the April 2020 issue of the Journal.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share